GSK-208136/007 (MeMuRu-OKA-007)

Study to assess consistency of 3 production lots of GSK Biologicals' combined measles-mumps-rubella-varicella vaccine in terms of immunogenicity and safety, compared to administration of GSK Biologicals' measles-mumps-rubella vaccine and varicella vaccine in healthy children in their second year of life
Combined Measles, Mumps, Rubella, Varicella Vaccine
208136/007 (MeMuRu-OKA-007)
Measles; Mumps; Rubella; Varicella
Phase 3
An annotated case report form is not available. A blank case report form will be provided. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
October 2015